Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-346821
Filing Date
2021-12-02
Accepted
2021-12-02 17:15:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d236540d424b5.htm 424B5 352146
2 GRAPHIC g236540g09h85.jpg GRAPHIC 96133
3 GRAPHIC g236540g12v45.jpg GRAPHIC 136094
4 GRAPHIC g236540g63p02.jpg GRAPHIC 33742
  Complete submission text file 0001193125-21-346821.txt   711233
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-238056 | Film No.: 211467756
SIC: 2834 Pharmaceutical Preparations